Published: July 12, 2026 | Category: Banking / Mergers & Acquisitions / Europe
Andrea Orcel is now close enough to touch what would be Europe’s largest bank merger in nearly two decades — and Berlin is still trying to stop him.
UniCredit, the Italian lender Orcel has run since 2021, said this week that its effective stake in Germany’s Commerzbank has risen to 47.6% of shares outstanding, translating into 49.65% of voting rights, after investors tendered shares representing 17.6% of the German bank’s capital by the July 3 deadline. That tender result, disclosed in a filing from UniCredit, includes a late surge of more than 5 percentage points during a two-week reopening period mandated by German takeover law — up sharply from the 12.5% UniCredit had secured before the extension. Combined with the 26.77% stake UniCredit already held directly, plus financial instruments conferring rights to a further 3.22%, the Italian bank now sits just short of outright majority control of shareholder meetings.
The math understates how contested this deal remains. Fewer than 2% of Commerzbank’s institutional and retail shareholders tendered their shares into the offer, a response Commerzbank’s own management has characterized as evidence of the bid’s “low attractiveness.” The German government, which holds a 12% stake left over from Commerzbank’s 2008 financial-crisis bailout, has publicly opposed the takeover, as have Commerzbank’s management board and its labor unions — an alignment of political, corporate and worker opposition that is unusual even by the standards of European bank consolidation, a field littered with failed cross-border tie-ups.
Stake Breakdown
| Component | Figure |
|---|---|
| Direct stake held before tender offer | 26.77% |
| Shares tendered by July 3 deadline | 17.6% of capital |
| — of which tendered during 2-week reopening | >5 percentage points |
| Tendered stake before extension | 12.5% |
| Financial instruments (physical delivery rights) | 3.22% |
| Total effective stake | 47.6% of shares outstanding |
| Voting rights controlled | 49.65% |
| German government’s residual stake | 12% (since 2008 bailout) |
| Retail/institutional shareholder tender participation | <2% |
| UniCredit’s original stake-building start date | September 2024 |
UniCredit’s own account of its strategy has shifted over time. When it launched its initial tender offer in May, the bank said it was not seeking control outright, but wanted to push its stake above 30% so it could keep buying shares on the open market without tripping Germany’s mandatory full-bid threshold. Having built its original 26.7% position gradually since September 2024 — largely through derivatives and market purchases that drew criticism in Berlin for their lack of transparency — UniCredit has now moved well past that stated threshold and within reach of formal control.
The remaining obstacle is regulatory, not just political. The European Central Bank, which holds final supervisory authority over euro-area bank mergers, has for years pushed publicly for more cross-border consolidation in a European banking sector it considers too fragmented to compete with U.S. rivals on scale. That puts Frankfurt’s supervisory arm on a collision course with Berlin’s political arm, which has treated Commerzbank — a lender to the German industrial Mittelstand and a symbol of postwar financial sovereignty — as a national asset worth protecting from foreign control.
Should the deal proceed toward a full combination, it would create a bank with a balance sheet spanning Italy and Germany, the eurozone’s two largest economies, and would test whether the ECB’s institutional preference for consolidation can actually override a national government’s objections when a marquee domestic lender is the target. Every prior attempt at cross-border bank M&A in the eurozone — including Commerzbank’s own aborted merger talks with Deutsche Bank in 2019 — has stalled over similar tensions between supervisory ambition and national politics. UniCredit’s tender result gives Orcel more leverage than any acquirer has had in this fight to date, but leverage over shareholders is not the same as leverage over Berlin.
Bloom Capital Review 
Leave a comment